From wiki-pain
Revision as of 08:35, 21 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.67
First Reported 1989
Last Reported 2010
Negated 1
Speculated 0
Reported most in Abstract
Documents 6
Total Number 6
Disease Relevance 3.99
Pain Relevance 2.74

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (ADRA1D) plasma membrane (ADRA1D) cell-cell signaling (ADRA1D)
DNA metabolic process (ADRA1D) signal transducer activity (ADRA1D)
Anatomy Link Frequency
fat cell 1
dorsal horn 1
ADRA1D (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 3 99.64 Very High Very High Very High
Dorsal horn 3 99.40 Very High Very High Very High
Potency 2 97.88 Very High Very High Very High
Chronic pancreatitis 8 95.72 Very High Very High Very High
Spinal cord 1 95.56 Very High Very High Very High
intrathecal 5 93.12 High High
Clonidine 1 92.80 High High
allodynia 7 92.20 High High
agonist 3 87.48 High High
adenocard 1 87.48 High High
Disease Link Frequency Relevance Heat
Obesity 9 98.80 Very High Very High Very High
Herpes Simplex Virus Infection 5 98.64 Very High Very High Very High
Inflammatory Bowel Disease 10 98.38 Very High Very High Very High
Primary Sclerosing Cholangitis 5 97.28 Very High Very High Very High
Pancreatitis 9 95.72 Very High Very High Very High
Neuropathic Pain 7 92.20 High High
Herpes Zoster 1 81.52 Quite High
Post Operative Pain 3 79.52 Quite High
Fibrosis 2 78.96 Quite High
Disease 2 75.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The localization and density of the three messenger RNAs closely resembled those of other rare (alpha2, alpha5 and beta1) transcripts but their distribution also overlapped that of the predominant alpha1, beta2 and gamma2 subunit transcripts.
Transcription (transcripts) of alpha1
1) Confidence 0.67 Published 1998 Journal Neuroscience Section Abstract Doc Link 9740400 Disease Relevance 0 Pain Relevance 0.13
Glycine receptor alpha1-subunit mRNA was decreased in the lumbar dorsal horn at the herpetic, but not postherpetic stage, without alteration in alpha3-subunit mRNA.
Neg (without) Transcription (decreased) of alpha1 in dorsal horn associated with dorsal horn and herpes simplex virus infection
2) Confidence 0.67 Published 2010 Journal J. Pharmacol. Sci. Section Abstract Doc Link 20173309 Disease Relevance 1.25 Pain Relevance 1.26
Expression of mRNA for collagen alpha1(I), alpha-smooth muscle actin or CTGF were all increased and co-localized exclusively to activated PSC in ACP.
Transcription (Expression) of alpha1 in PSC associated with primary sclerosing cholangitis and chronic pancreatitis
3) Confidence 0.67 Published 2010 Journal Lab. Invest. Section Abstract Doc Link 20368699 Disease Relevance 1.30 Pain Relevance 0.70
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that the glycine receptor alpha1, alpha2, beta subunits and gephyrin mRNAs were expressed at comparable levels in strychnine-treated and untreated cultures.
Transcription (expressed) of alpha1
4) Confidence 0.52 Published 1998 Journal J. Cell. Sci. Section Abstract Doc Link 9427682 Disease Relevance 0 Pain Relevance 0.09
The levels of expression of Na+, K+-ATPase alpha1- and beta1-isoform proteins were also lower in UC patients than in controls, although there were no differences in Na+, K+-ATPase alpha1- and beta1-isoform mRNA levels between the two groups.
Transcription (levels) of alpha1 associated with inflammatory bowel disease
5) Confidence 0.52 Published 2004 Journal J. Pathol. Section Abstract Doc Link 15307141 Disease Relevance 0.78 Pain Relevance 0.07
For alpha-2 antagonists, the potency order was: yohimbine greater than idazoxan greater than SK&F-86,466 much greater than benextramine; 3) a description of the impact of benextramine (irreversible alpha-1/alpha-2 antagonist) on human fat cell alpha-2 adrenergic receptors and on human fat cell function; the drug inactivates the alpha-2 adrenergic receptors with a minor impact on beta adrenergic receptors and without noticeable alterations of fat cell function as assessed by preservation of beta adrenergic and Al-adenosine receptor-mediated lipolytic responses; and 4) a definition of the relationship existing between alpha-2 adrenergic receptor occupancy, inhibition of adenylate cyclase activity and antilipolysis with full and partial agonists.
Transcription (description) of alpha-1 in fat cell associated with adenocard, antagonist, obesity, agonist and potency
6) Confidence 0.13 Published 1989 Journal J. Pharmacol. Exp. Ther. Section Abstract Doc Link 2566681 Disease Relevance 0.67 Pain Relevance 0.49

General Comments

This test has worked.

Personal tools